Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Tapestry, Inc. (TPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Tapestry, Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while Tapestry, Inc. trades at $115.67 (market cap $22.83B). The key difference: Tapestry, Inc. is far larger — about 5.7× Edgewise Therapeutics Inc. Common Stock's market cap, and Tapestry, Inc. pays a 1.61% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Tapestry, Inc. for 70 Days on average.
| EWTX | TPR | |
|---|---|---|
Market Cap | $4.02B | $22.83B |
Volume | 1,446,128 | 1,359,849 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $164.78 |
52-Week Low | $14.89 | $98.81 |
Typical Hold Time | 0 Days | 70 Days |
Enterprise Value | $3.56B | $25.63B |
Dividend Yield | — | 1.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TPR trades at $115.23, down 1.7% today, with neutral technical signals and strong analyst support. The stock shows robust profitability with 77.82% gross margins and has beaten earnings estimates for three consecutive quarters. Recent developments include expansion into Google's AI shopping ecosystem and accelerating international growth in China and Europe. The company maintains a solid balance sheet with $1.12 billion in cash and manageable debt levels.
TPR presents a compelling investment case with 73% analyst buy ratings and a $174.64 consensus price target representing 52% upside. Strong brand momentum and margin expansion potential are offset by tariff risks and Kate Spade execution challenges. The stock trades at reasonable valuations with a 15.85 P/E ratio, though recent net income decline from $816M to $183M warrants monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Tapestry, Inc.
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →
